Supply resilience
A domestic source for products that are import-dependent and shortage-prone, closer to the hospitals that rely on them.
Sterile manufacturing · Adelaide, South Australia
The sterile medicines Australia keeps running short of.
Elemental IV is establishing local, automated manufacturing of ready-to-use sterile injectable medicines, reducing Australia's reliance on imports and the shortages that put hospital care at risk.
~90%of Australia's sterile injectable medicines are sourced from overseas
Recurringshortages of critical injectables force rationing, substitution and emergency imports
By handmany ready-to-use infusions are not made here, so they are prepared manually at the bedside
The problem
A long, offshore supply chain for medicines hospitals cannot do without.
Australia depends on distant supply lines for the sterile medicines its hospitals use every day. When that chain breaks, and it does, repeatedly, hospitals ration, substitute, and fall back on costly emergency imports. Many ready-to-use presentations simply are not made here, so clinicians prepare them by hand, adding cost, delay and the risk of error at the point of care.
What we're building
Local, automated manufacturing for ready-to-use sterile medicines.
Elemental IV is establishing South Australian capability to manufacture finished, ready-to-administer sterile injectable products on an automated, robotic aseptic filling platform, the first of its kind in Australia. Made here, in ready-to-use form, these medicines shorten the supply chain, reduce manual preparation, and give hospitals a dependable domestic source.
Patient safety
Ready-to-administer presentations reduce manual preparation and the medication errors that come with it.
Sovereign capability
Local sterile manufacturing that strengthens Australia's medical supply chain and reduces dependence on imports.
Approach · where we are
Starting narrow, built properly from the outset.
We are at the foundation stage: defining the facility, the product set and the regulatory pathway in line with PIC/S and TGA expectations, and building the right partnerships in equipment, research and government to do it well. We are deliberately beginning with a small set of high-need products where local, ready-to-use supply matters most.
Foundations
Facility design, product selection and the regulatory pathway.
Manufacturing
GMP-aligned sterile manufacturing of ready-to-use products on an automated aseptic line.
Resilience
A reliable, sovereign source of Australia's essential sterile medicines.
Get in touch
Building this with us.
We would like to hear from investors, hospital and health partners, and collaborators who want a more resilient supply of Australia's sterile medicines.
storme@elemental-iv.com